Research Pipeline
NORDBIOTIC™ IBS 10
Randomized placebo-controlled clinical trial on a unique 10-strain combination. Proven efficacy within gastrointestinal health.

NORDBIOTIC™ GASTRO ONE BI040
Randomized placebo-controlled clinical trial on a carefully selected bifido lactis extra stable strain. Proven efficacy within gastrointestinal health.

NORDBIOTIC™ GASTRO ONE BC 300
Randomized placebo-controlled clinical trial performed on a unique bacillus strain proving gastrointestinal health. The bacillus strain holds huge potential for supplements and the food matrix due to superior stability capabilities.

NORDBIOTIC™ IMMUNOVIR
Randomized placebo controlled clinical trial on a unique strain combination for reduction of the impact of viral manifestation and immune boost response on SARS COV-2 example.

NORDBIOTIC™ FeMAX
In Vitro study on selected lactobacillus to improve iron absorption and minimize side-effects from the iron source.

NORDBIOTIC™ Gluten digest
In vitro study on strains of lactobacilli and streptococcus. Proven ability to digest immunotoxic gluten peptides. Patent application no. P.447563

NORDBIOTIC™ Target-shield
In vitro susceptibility study on strains of lactobacilli and bifidobacteria to design the most efficient probiotic mixture for specific antibiotic treatment.

NORDBIOTIC™ OSTEODUO
Randomized placebo-controlled clinical trial conducted on patent-deposited Lactobacillus strains, supporting stronger bone health and overall bodily strength.

NORDBIOTIC™ LIPID CONTROL BC
Randomized placebo-controlled clinical trial on a unique bacillus strain with proven efficacy in the management of cholesterol levels.

NORDBIOTIC™ HORMONE CONTROL
NORDBIOTIC™ HORMONE CONTROL
Randomized placebo controlled clinical trial on a carefully selected bacteria for the support of endocrine health.

NORDBIOTIC™ STRESS-BRAIN
NORDBIOTIC™ STRESS-BRAIN
